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INTRODUCTION
Normal epithelial cells of the mammary gland are able to 
synthesize lipids, carbohydrates, and proteins. Breast cancer is 
histologically classified into subtypes according to the substances 
that the carcinoma cells contain-such as lipid-rich carcinoma 
and glycogen-rich carcinoma, while the types of carcinoma 
are mainly ductal carcinoma and lobular carcinoma. Aboum-
rad et al. [1] reported the first case of mammary carcinoma 
that contained lipids in the cytoplasm, which was diagnosed 
as lipid-secreting carcinoma. Lipid-rich carcinoma is a rare 
mammary cancer, and glycogen-rich carcinoma is also rela-
tively rare. To the best of our knowledge, only 1 other case of 
invasive mammary carcinoma with composite histologic find-
ings of these 2 carcinomas has been described [2]. We encoun-
tered a case of intraductal carcinoma with the coexistence of 
these 2 rare subtypes of mammary carcinoma, and performed 
a histological and ultrastructural examination of the lesion.
CASE REPORT
A Japanese woman in her fifth decade visited our hospital 
in order to be examined and medically treated for multiple 
small linear calcifications that were found in her left breast by 
mammography. No tumor was detected on palpation. The     
results of mammography, echography, and magnetic resonance 
imaging (Figure 1), suggested the presence of malignancy. On 
aspiration cytology, no cells were obtained. Breast-conserva-
tion surgery was performed. The tumor was macroscopically 
indistinct and had a diameter of 30 mm. The intraductal car-
cinoma was extended, and invasion to the surrounding tissue 
was not found (Figure 2). Small foci of linear calcification and 
necrosis were seen in the ducts that were occupied by tumor 
cells, and these exhibited a comedo pattern. There were no 
abundant secretory materials. In three-fourths of the lesions, 
the tumor cells had clear and abundant cytoplasm and com-
pressed crescent-shaped or oval nuclei (Figure 3). The cyto-
plasm was vacuolated. Among these cells, some had atypical 
large nuclei with distinct nucleoli, and some had small round 
nuclei and modest eosinophilic cytoplasm-so-called “fried-egg 
cells” (Figure 4A). Each of the components presented different 
characteristics. The former were negative for periodic acid-Schiff 
stain (PAS), and the latter were positive. After treatment with 
diastase, the cells were negative for PAS (Figure 4B, C). Im-
munohistochemically, both types of cells were diffusely positive 
for cytokeratin (AE1/AE3) and focally positive for gross cystic 
disease fluid protein-15 (GCDFP-15), and were negative for 
vimentin, S-100 protein, smooth muscle actin and CD10. The 
carcinoma cells of both lipid-rich carcinoma and glycogen-rich 
carcinoma are immunohistochemically positive for estrogen 
(ER) and progesterone receptors, and negative for HER2. An 
ultrastructural study revealed lipid droplets in the cytoplasm 
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of the vacuolated cells (Figure 1). However, glycogen particles 
were not shown. No nodal metastasis was found.
DISCUSSION
Lipid-rich carcinoma is a rare subtype of breast cancer that 
is histologically characterized by cells with numerous large and 
small vacuoles in their cytoplasm. The cells of lipid-rich carci-
noma are divided into the following 3 forms: the histiocytoid 
type, the sebaceous type, and the type with apocrine extrusion 
of nuclei [3]. Two or 3 of these types often exist together, as in 
this case, where the histiocytoid and sebaceous types were   
observed. Fat staining of cryostat sections revealed the pres-
ence of a large amount of lipid within the cytoplasm. Lipid   
accumulation was also shown in an ultrastructural study. Never-
theless, the definition of lipid-rich carcinoma is controversial 
because it is unclear as to what percentage of vacuolated cells 
and which type of origin of the lipid vacuoles should confirm 
the diagnosis [4]. In our case, about 75% of the tumor cells had 
lipid-rich cytoplasm. Ramos and Taylor [5] have shown by elec-
tron microscopy that lipids originate from a secretory product 
of the neoplastic cells, and they do not consist of a degenera-
tive material. They described the secretory vacuoles as being 
close to a markedly prominent Golgi apparatus, and the absence 
of autophagic vacuoles and the presence of prominent rough 
endoplasmic reticulum supported this speculation. Vera-Sem-
pere and Llombart-Bosch [6] suggested a similar origin of     
the secretory product. However, Wrba et al. [7] reported no 
immunohistochemical or ultrastructural findings that could 
support the lipid secretion of carcinoma cells in their cases. 
Therefore, in their opinion, the term lipid-rich carcinoma, rather 
Figure 1. Mammography findings. Multiple small linear calcifications are 
seen in the left breast.
Right Left
Figure 2. The border of the tumor is unclear, and mass formation is not 
observed (H&E stain, ×1).
Figure 3. (A) Intraductal lipid-rich carcinoma. Neoplastic cells with vacu-
olated cytoplasms fill the mammary ducts. A comedo pattern with central 
necrosis is seen (H&E stain,  ×100). (B) Electron microscopy showed 
lipid droplets (arrows) in the cytoplasm of tumor cells.
A B
A B C
Figure 4. A component of glycogen-rich car-
cinoma (A, H&E stain, ×200; B, periodic acid-
Schiff stain [PAS], ×200; C, PAS after diastase 
digestion,  ×200). Cells with a small round   
nucleus and eosinophilic cytoplasm (A) are 
positive for periodic acid-Schiff stain (B), after 
treatment of diastase, negative for PAS (C).IntraductalLipid-RichCarcinoma 137
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than lipid-secreting carcinoma, should be used, unless there is 
evidence of active lipid secretion.
Neoplasms of the breast that have clear cytoplasm occur in 
a variety of diseases, such as lipid-rich carcinoma, glycogen-
rich carcinoma, apocrine carcinoma, secretory carcinoma, clear-
cell myoepithelioma, and clear-cell adenomyoepithelioma. In 
addition, soft-tissue neoplasms of the breast and chest wall, 
for example, clear-cell sarcoma, clear-cell rhabdomyosarcoma, 
and alveolar soft-part sarcoma, also need to be discriminated 
[8,9]. Skin tumors with clear cytoplasm must be distinguished 
too. Metastatic renal cancer of the clear-cell type of carcinoma 
has been reported, but they are highly rare [10]. In breast carci-
nomas, PAS stain and immunostaining are useful in the differ-
ential diagnosis. For example, glycogen-rich carcinoma and 
apocrine carcinoma are positive for PAS, and lipid-rich carci-
noma is negative. Glycogen granules in glycogen-rich carci-
noma become negative for PAS after diastase digestion; on the 
other hand, granular cytoplasm of apocrine carcinoma keeps 
positive for PAS after that treatment. Positive immunostain for 
the S-100 protein has been reported to be useful in the diagnosis 
of lipid-rich carcinoma [11], although in our case, immunos-
taining for this protein was negative; however, this is not useful 
in the differentiation between lipid-rich carcinoma and myo-
epithelial tumors. Immunostaining for smooth muscle actin, 
which is reactive in myoepithelial cells, is helpful in such cases. 
S-100 protein is frequently expressed in secretory carcinoma, 
too. But, most of secretory carcinomas are negative for ER. 
Soft-tissue tumors that have clear cytoplasm are ruled out by 
immunoreactivity for vimentin and negative stains for AE1/
AE3 and GCDFP-15. GCDFP-15 has been reported to be use-
ful in differentiating between primary breast carcinoma and 
metastatic carcinoma [12]. Metastatic clear cell renal cell car-
cinoma is positive for vimentin and CD10, and negative for 
GCDFP-15. In addition, GCDFP-15 is useful in the differential 
diagnoses among some primary breast carcinomas. Apocrine 
carcinoma indicates diffuse and intensive positive for GCDFP- 
15, but secretory carcinoma indicates negative for it.
A lesion with a combination of lipid-rich carcinoma and 
glycogen-rich carcinoma was reported by Kovacs and Krutsay 
[2]. In the present lesion, some of the carcinoma cells had gly-
cogen in their cytoplasm. These cells had the same histological 
characteristic features as glycogen-rich carcinoma in that the 
cells had round nuclei at the center of pale eosinophilic cyto-
plasm and were positive for PAS and sensitive to diastase diges-
tion. Glycogen, which can be demonstrated by electron micros-
copy [13], was not revealed in this case. This may have been 
because the electron microscopy was performed on paraffin-
embedded specimens. Both lipid-rich carcinoma and glyco-
gen-rich carcinoma are the diagnoses that are determined by 
the metabolic products in the cytoplasm, and these are differ-
ent from the diagnoses that are determined by the cellular types. 
However, diagnoses must be determined on the basis of not 
only examination of the intracytoplasmic products but also 
the histologic findings, because a varied amount of lipid and 
glycogen accumulation in cytoplasm was found in 30% and 
85%, respectively, of mammary carcinomas [14,15]. Glycogen 
has also been demonstrated in mammary squamous cell car-
cinoma. Histologic findings of clear, foamy, or vacuolated       
cytoplasm are important for the diagnosis of lipid-rich carci-
noma, and the findings of a fried-egg appearance are impor-
tant for the diagnosis of glycogen-rich carcinoma.
Clinically, early detection of mammary lipid-rich carcinoma 
is presumed to be difficult. Except for a few reports that did 
not mention whether the carcinoma was invasive or intraduct-
al, all reported cases of lipid-rich carcinoma were invasive. The 
ratio of intraductal carcinoma to invasive carcinoma in lipid-
rich carcinoma was lower than that in ductal carcinoma. This 
is not only because of the low incidence of lipid-rich carcino-
ma but also because of the difficulty in detecting it. In the pres-
ent case, the tumor was not palpable. Calcifications that were 
detected by medical examination led to the early discovery in 
this case.
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